Related Experiment Video

Updated: Jun 19, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
14:04

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria

Published on: May 8, 2013

Antibiotic resistance in community-acquired pneumonia caused by Streptococcus pneumoniae, methicillin-resistant

Pak-Leung Ho1, Vincent Chi-Chung Cheng1, Chung-Ming Chu2

  • 1Department of Microbiology and Centre of Infection, Queen Mary Hospital, University of Hong Kong, Hong Kong SAR, People's Republic of China.

Chest
|October 8, 2009
PubMed

Insights

Community-acquired pneumonia (CAP) treatment is guided by likely pathogens, including drug-resistant Streptococcus pneumoniae, Staphylococcus aureus, and Acinetobacter baumannii. This review covers their epidemiology, clinical features, and management strategies.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pulmonology

Background:

  • Antimicrobial therapy is the primary treatment for community-acquired pneumonia (CAP).
  • Treatment decisions for CAP are influenced by pathogen etiology, local antimicrobial resistance patterns, and patient-specific factors.
  • Emerging antimicrobial resistance in common CAP pathogens necessitates updated treatment guidelines.

Purpose of the Study:

  • To review the recent epidemiology, microbiology, clinical features, and treatment of CAP caused by specific antimicrobial-resistant pathogens.
  • To highlight the impact of Streptococcus pneumoniae, community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA), and Acinetobacter baumannii on CAP management.
  • To inform clinical practice and guideline development for CAP caused by resistant organisms.

Main Methods:

  • Literature review of recent epidemiological data.
  • Analysis of microbiological characteristics of key pathogens.
  • Synthesis of clinical features and treatment outcomes for CAP caused by resistant bacteria.

Main Results:

  • Streptococcus pneumoniae remains a leading cause of CAP, with evolving susceptibility patterns influencing empirical treatment.
  • Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) is an emerging concern due to its resistance and association with severe, rapidly progressive pneumonia.
  • Acinetobacter baumannii is increasingly recognized as a cause of CAP in tropical regions, particularly in Australia and Asia.

Conclusions:

  • Effective management of CAP requires understanding the epidemiology and resistance patterns of key pathogens.
  • Antimicrobial resistance poses a significant challenge to empirical CAP treatment, necessitating careful selection of agents and dosages.
  • Further research and updated guidelines are crucial for addressing the growing threat of antimicrobial-resistant pathogens in CAP.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...